Metabolic studies of allopurinol, an inhibitor of xanthine oxidase
- 1 July 1966
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 15 (7) , 863-880
- https://doi.org/10.1016/0006-2952(66)90163-8
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- The effect of allopurinol (HPP) in the treatment of goutArthritis & Rheumatism, 1965
- The Study of Purine Utilization and Excretion in a Xanthinuric Man*Journal of Clinical Investigation, 1965
- The Renal Excretion of Oxypurines*Journal of Clinical Investigation, 1965
- Effect of allopurinol (4-Hydroxypyrazolo-(3,4-d)pyrimidine) on serum and urinary uric acid in primary and secondary goutThe American Journal of Medicine, 1964
- Clinical, physiological and biochemical studies of a patient with xanthinuria and pheochromocytomaThe American Journal of Medicine, 1964
- Potentiation by inhibition of drug degradation : 6-substituted purines and xanthine oxidaseBiochemical Pharmacology, 1963
- Potential Purine Antagonists. I. Synthesis of Some 4,6-Substituted Pyrazolo [3,4-d] pyrimidines1Journal of the American Chemical Society, 1956
- Tubular transport mechanismsThe American Journal of Medicine, 1950
- Aniline Hydrogen Phthalate as a Spraying Reagent for Chromatography of SugarsNature, 1949
- Über die Bestimmung kleiner Pentosemengen, insbesondere in Derivaten der AdenylsäureHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1939